ARCHIVES

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

This article is from The Cancer Letter archive.

Vol. 23 No. 18 | May 9, 1997

Download PDF Visit The Full Archive

Related Articles

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

October 14, 2005

Organ Site Program Fate On Line, Gets Review Next Week

November 20, 1981

FDA says green tea unlikely to prevent cancer.

July 8, 2005

“Wild West” of Molecular Testing?: Caris Engaged in Aggressive Marketing, Improper Medicare Billing, Lawsuit Alleges

August 8, 2014

NCI To Merge Two Intramural Divisions To Form Center For Cancer Research.

January 12, 2001

Obey Erred On Criticism Of Pap Test Cost, FCRC Construction

August 10, 1979